Back to news
finance

Boots Considers Divestment Valued at $10 Billion, Potentially Shelving London Stock Market Debut

Boots, a prominent retail pharmacy chain, is reportedly engaged in discussions for a sale that could reach an estimated $10 billion. This development suggests the company might abandon its previous intentions for an initial public offering in London.

6/24/2026, 8:16:45 PM

Boots, the well-known health and beauty retailer, is reportedly exploring a change in ownership, with a potential transaction valued around $10 billion. This consideration could lead to the cancellation of its earlier plans for listing on the London stock exchange. According to Investing.com, the pharmacy giant, currently under the corporate umbrella of Walgreens Boots Alliance, has been evaluating various strategic options for its future. The retail business, a familiar presence across the United Kingdom, has been a subject of considerable market speculation regarding its long-term direction. Sources cited by Investing.com indicate that preliminary conversations are underway with prospective buyers. These discussions are focused on a direct sale of the company, which would offer Walgreens Boots Alliance an alternative to a public offering. Previously, Reuters had highlighted that Walgreens Boots Alliance had engaged Goldman Sachs to assist in a potential sale of Boots. The American parent company had been looking at shedding non-core assets to streamline its operations and focus on its primary pharmaceutical business in the United States. The idea of a London IPO for Boots had circulated for some time, with analysts suggesting it could provide a significant valuation for the venerable British brand. However, the current economic climate and market conditions might be influencing the decision to favor a direct sale over a public listing. Should the sale proceed at the reported valuation, it would mark a substantial corporate acquisition within the retail and healthcare sectors. The outcome of these discussions will determine the future trajectory of Boots, a chain with a long history and a significant presence in the UK consumer market. The potential divestment aligns with a broader trend of large conglomerates re-evaluating their portfolios and divesting assets to optimize their business structures. Investors will be keenly watching for further announcements from Walgreens Boots Alliance regarding the future of its UK retail arm.

Share